CooperCompanies will report Q2 2025 financial results on May 29, followed by a conference call.
Quiver AI Summary
CooperCompanies, a leading medical device company based in San Ramon, California, announced it will release its second quarter 2025 financial results on May 29, 2025, at 4:15 PM ET. A conference call to discuss these results and corporate developments will follow at 5:00 PM ET, with a dial-in number provided for participants. The company's focus is on enhancing lives through its two business units, CooperVision, which specializes in contact lenses, and CooperSurgical, dedicated to fertility and women's healthcare. With over 16,000 employees and a presence in more than 130 countries, CooperCompanies impacts over fifty million lives annually.
Potential Positives
- Announcement of Q2 2025 financial results and conference call signifies transparency and commitment to keeping investors informed.
- Company's strong global presence, selling products in over 130 countries, reflects a robust market position and growth potential.
- CooperCompanies' focus on improving quality of life through its product lines highlights a strong mission and aligns with positive public interest in healthcare advancements.
- The large workforce of over 16,000 indicates a significant operational capacity and potential for continued business development and innovation.
Potential Negatives
- None
FAQ
When will CooperCompanies report its second quarter 2025 financial results?
CooperCompanies will report its second quarter 2025 financial results on Thursday, May 29, 2025, at 4:15 PM ET.
How can I listen to CooperCompanies' conference call?
You can listen to the conference call by dialing 800-715-9871 and using the conference ID 1515103.
Is there an audio webcast available for the financial results announcement?
Yes, a simultaneous audio webcast and subsequent replay will be available at http://investor.coopercos.com.
What are the main business units of CooperCompanies?
CooperCompanies operates through two main business units: CooperVision and CooperSurgical, focusing on vision and women's healthcare.
Where is CooperCompanies headquartered?
CooperCompanies is headquartered in San Ramon, California.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$COO Hedge Fund Activity
We have seen 306 institutional investors add shares of $COO stock to their portfolio, and 327 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 2,957,421 shares (+517.0%) to their portfolio in Q4 2024, for an estimated $271,875,712
- GOLDMAN SACHS GROUP INC added 2,352,296 shares (+138.8%) to their portfolio in Q4 2024, for an estimated $216,246,571
- VIKING GLOBAL INVESTORS LP added 2,025,310 shares (+inf%) to their portfolio in Q4 2024, for an estimated $186,186,748
- IMPAX ASSET MANAGEMENT GROUP PLC removed 1,766,500 shares (-89.9%) from their portfolio in Q1 2025, for an estimated $149,004,275
- CITADEL ADVISORS LLC removed 1,384,135 shares (-99.9%) from their portfolio in Q4 2024, for an estimated $127,243,530
- FMR LLC added 1,095,805 shares (+97.6%) to their portfolio in Q4 2024, for an estimated $100,737,353
- UBS GROUP AG added 1,067,403 shares (+172.1%) to their portfolio in Q4 2024, for an estimated $98,126,357
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
SAN RAMON, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today it will report second quarter 2025 financial results on Thursday, May 29, 2025, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.
The dial-in number for the call is 800-715-9871 and the conference ID is 1515103. A simultaneous audio webcast and subsequent replay can be accessed at http://investor.coopercos.com .
About CooperCompanies
CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on helping people experience life’s beautiful moments through its two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, helping to improve the way people see each day. CooperSurgical is a leading fertility and women’s healthcare company dedicated to putting time on the side of women, babies, and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies has a workforce of more than 16,000, sells products in over 130 countries, and positively impacts over fifty million lives each year. For more information, please visit
www.coopercos.com
.
Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
[email protected]
